MannKind Corporation (MNKD) vs Omada Health (OMDA)
A side-by-side comparison of MannKind Corporation and Omada Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MNKD
MannKind Corporation
$3.80HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
OMDA
Omada Health
$20.61HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — MNKD vs OMDA
growth of $100 · dividends reinvested · last 1yMNKD -8.0% (-8.0%/yr)OMDA -8.9% (-8.9%/yr)MNKD compounded faster over this window
MNKD OMDA
MNKD vs OMDA: by the numbers
- •OMDA is the larger company ($1.23B vs $1.21B market cap).
- •OMDA is profitable (1.39% net margin) while MNKD runs a net loss (-11.08%).
Metrics side by side
Valuation
| Metric | MNKD | OMDA |
|---|---|---|
| P/E ratio | N/A | 327.19 |
| P/S ratio | 3.08 | 3.96 |
| P/B ratio | N/A | 4.85 |
| EV / EBITDA | 52.18 | 144.65 |
| FCF yield | N/A | 1.64% |
Profitability
| Metric | MNKD | OMDA |
|---|---|---|
| Gross margin | 75.69% | 68.19% |
| Operating margin | 11.12% | -0.15% |
| Net margin | -11.08% | 1.39% |
| ROE | N/A | 1.70% |
| ROIC | 1.32% | -0.18% |
Growth (annualized)
| Metric | MNKD | OMDA |
|---|---|---|
| Revenue CAGR (5Y) | 39.51% | N/A |
| Total return CAGR (5Y) | -4.18% | N/A |
Frequently asked
- Is MNKD or OMDA more profitable?
- OMDA runs the higher net margin — MNKD at -11.08% versus OMDA at 1.39%.
Go deeper
Dig into the metrics
Omada Health P/E ratioMannKind ROEOmada Health ROEMannKind operating marginOmada Health operating marginMannKind revenue growthOmada Health revenue growthMannKind free cash flowOmada Health free cash flow
MannKind & Omada Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.